Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 10, 2002, Pages 3292-3297

  Pluymers, Wim ^a   Pais, Godwin ^a   Van Maele, Bénédicte ^a   Pannecouque, Christophe ^a   Fikkert, Valery ^a   Burke Jr , Terrence R ^a   De Clercq, Erik ^a   Witvrouw, Myriam ^a   Neamati, Nouri ^a   Debyser, Zeger ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DIKETONE; INTEGRASE; L 708906; NELFINAVIR; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURE ANALYSIS; VIRUS DNA CELL DNA INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN;

ACETOACETATES; ANIMALS; CELLS, CULTURED; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HIV-1; HIV-2; HUMANS; MICROBIAL SENSITIVITY TESTS; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 0036784324     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.10.3292-3297.2002     Document Type: Article

References (26)

1. Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro
2. DNA-dependent protein kinase is not required for efficient lentivirus integration
3. Integration of retroviral DNA
4. Activities of human immunodeficiency virus (HIV) integration protein in vitro: Specific cleavage and integration of HIV DNA
5. A quantitative assay for DNA integration in vivo
6. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1
7. Assays for the evaluation of HIV-1 integrase inhibitors
8. In search of authentic inhibitors of HIV-1 integration
9. The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
10. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase
11. Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)
12. Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein
13. Integration of human immunodeficiency virus type 1 DNA in vitro
14. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules
15. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design
16. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
17. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells
18. Structural determinants for HIV-1 integrase inhibition by beta-diketo acids
19. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
20. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
21. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters
22. HIV-1 integration as a target for antiretroviral therapy: A review
23. Retroviral integrase inhibitors year 2000: Update and perspectives
24. Integration is essential for efficient gene expression of human immunodeficiency virus type 1
25. Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity
26. 4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells